Cardiovascular News Issue 35 – September 2014

5721

Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -Fractional flow reserve is safe and feasible in NSTEMI patients -Sanjit Jolly: TASTE -Tim Fischell: Renal denervation -Profile: Sunil Rao